You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. A Culturally and Linguistically Specific Deaf Depression Screener

    SBC: SOCIAL SCIENCES INNOVATIONS CORPORATION            Topic: NCATS

    DESCRIPTION (provided by applicant): Hearing impairment/deafness is the most common sensory limitation in the U.S. An estimated 11 million individuals in the US are deaf or hard-of-hearing. It has been estimated that approximately 1 million Americans use American Sign Language (ASL) as their primary means of communication making it a distinct linguistic minority. This proposal seeks to improve cli ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  2. A Data-mining Approach to CAM Medication Reconciliation

    SBC: Transcendent International, LLC            Topic: NCATS

    DESCRIPTION (provided by applicant): Due to its complex, multi-herb nature, many patients who use Complementary and Alternative Medicine (CAM) do not have full knowledge of the ingredients included in their remedies. Lack of disclosure about CAM can placepatients at risk, as some herbal products can have adverse interactions with pharmaceuticals or cause harmful side effects. This proposal seeks t ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  3. A Minimally Invasive Cardiac Output Monitoring Device for Critically Ill Patients

    SBC: RETIA MEDICAL, LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Cardiac output (CO) monitoring can improve the outcomes of critically ill patients via early detection and diagnosis of disease and goal-directed therapy. Yet, CO monitoring has sharply declined due to its invasiveness.Retia Medical will offer a device that computes CO by mathematical analysis of minimally invasive and non-invasive physiologic waveforms that ar ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  4. A Multi-channel Web Platform to Provide Holistic Care to Underserved Consumers

    SBC: Transcendent International, LLC            Topic: NIMHD

    DESCRIPTION (provided by applicant): Significant obstacles exist in care delivery that prevents meaningful utilization of mental health services by consumers who experience health disparities. Specifically, individuals facing isolation due to linguistic, literacy, or cultural bariers often face challenges in procuring mental health care. These challenges are in part due to the medical and mental s ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  5. An agent for the treatment of lung cancer

    SBC: Medicon            Topic: NCI

    DESCRIPTION (provided by applicant): Lung cancer is the leading cause of cancer deaths in the US and worldwide. Given its prevalence, morbidity and mortality, it is clear that in terms of treatment, the lung cancer problem is far from solved; and thatnew agents are urgently needed. Our preliminary data indicate that the novel compound phospho-sulindac (PS) is potentially highly effective agai ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  6. An application enabling trainers to rapidly generate, customize and manage online

    SBC: DEEPSEMAPHORE, LLC            Topic: NIEHS

    DESCRIPTION (provided by applicant): Project summary: The project summary with the exception of the first five lines contains proprietary/privileged information that Dr. Ramloll requests not be released to persons outside the Government, unless for purposes of review and evaluation. (Number of lines in paragraph below = 30) Given the growing body of research results reporting the benefits of usi ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  7. A New Normothermic Solution for Protecting Avulsed Teeth Prior to Re-implantation

    SBC: CELL PRESERVATION SERVICES INC            Topic: NIDCR

    DESCRIPTION (provided by applicant): The science of protecting avulsed teeth has progressed little in the past 10 years. While commercial solutions are available, most simply consist of a pH balanced salt solution. Several peer-reviewed citations in the last two years have compared the efficacy of Save-A-Tooth, other salt formulations, coconut water and milk as candidates for maintaining avulsed t ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  8. An inhaled PDGF receptor inhibitor for the treatment of pulmonary arterial hyper

    SBC: Pulmokine, Inc.            Topic: NHLBI

    DESCRIPTION (provided by applicant): The purpose of this Phase II project is to develop a new treatment for pulmonary arterial hypertension (PAH) consisting of the inhaled platelet derived growth factor receptor (PDGFR) inhibitor PK10453. PAH is a diseaseof the pulmonary vasculature associated with high morbidity and mortality. Signaling through the PDGFR leads to smooth muscle cell proliferation ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  9. An Innovative Cardioprotective

    SBC: Angion Biomedica Corp.            Topic: NHLBI

    DESCRIPTION (provided by applicant): Myocardial infarction (MI) is a significant cause of morbidity and mortality in the U.S. H2 Relaxin (H2R) is a Phase III clinical trial-stage peptide that exhibits both anti-inflammatory and cytoprotective activities which can potentially be harnessed for the treatment of MI via use as adjuvant to recanalization therapy. However, clinical administration of rhH2 ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Anion Exchange Resin for Chirality-based Separation of Single-wall Carbon Nanotubes

    SBC: Sepax Technologies, Inc.            Topic: N/A

    Sepax Technologies, Inc. has identified a new type of anoin-exchange resin which separates single-wall carbon nanotubes (SWCNTs) with >80% recovery yield and resolves in a single pass the chiral tubes of (6,5) well from commercial SWCNT starting materials by Chromatography. Improvement and scale up of the targeted resin production will facilitate the separation of chiral nanotubes for the academic ...

    SBIR Phase II 2012 Department of CommerceNational Institute of Standards and Technology
US Flag An Official Website of the United States Government